Overview

Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate the efficacy and safety of GRT6005 in patients with painful diabetic neuropathy.
Phase:
Phase 2
Details
Lead Sponsor:
Grünenthal GmbH
Tris Pharma, Inc.
Collaborator:
Forest Laboratories
Treatments:
Analgesics